| Feature | Details |
|---|---|
| Molecular Weight | ~14 kDa |
| Receptor Complex | IL-21R + γc |
| Signaling Pathways | JAK/STAT, PI3K/AKT, MAPK/MEK, IRF4 |
| Precursor Structure | 17-amino acid signal peptide + 129-amino acid mature chain |
IL-21 drives terminal differentiation of NK cells, characterized by:
Upregulation of CD94-NKG2A (inhibitory receptor) and CD154 (activation marker)
Enhanced cytotoxicity (perforin-dependent) and cytokine production (IFN-γ, IL-10)
CD8+ T Cells: Co-stimulates activation, proliferation, and survival .
Regulatory T Cells (Tregs): Inhibits generation and suppressive function .
Suppresses IgE class-switching via STAT3-mediated inhibition of germline ε transcription .
Promotes plasma cell differentiation and memory B cell formation .
| Cell Type | Key Effects |
|---|---|
| NK Cells | ↑ Cytotoxicity, ↑ IFN-γ/IL-10, ↓ NK1.1, ↑ CD94-NKG2A |
| CD8+ T Cells | ↑ Proliferation, survival, and antitumor activity |
| B Cells | ↓ IgE production, ↑ plasma cell differentiation |
Metastasis Reduction: IL-21 treatment reduces B16F10 melanoma lung/liver metastases by >80% in wild-type mice, dependent on NK cells and perforin .
Tumor Rejection: IL-21-transduced tumors (e.g., B16F1 melanoma) are rejected via NK- and CD8+ T cell-mediated cytotoxicity .
Therapeutic Vaccination: Three doses of irradiated IL-21-expressing tumor cells cure 70% of mice with established tumors .
Allergy: Suppresses IgE production and mast cell degranulation in hypersensitivity models .
Autoimmunity: Ameliorates rheumatoid arthritis in murine models by blocking IL-21/IL-21R interactions .
While murine studies highlight IL-21’s therapeutic potential, translational challenges include balancing its proinflammatory effects (e.g., Th17 promotion) with immunosuppressive roles (e.g., Treg inhibition) . Combinatorial approaches with checkpoint inhibitors or adoptive cell therapy are under exploration .
IL-21 is a type I cytokine that plays crucial roles in regulating immune responses in mice. The primary cellular sources of IL-21 are activated CD4+ T cells, particularly T follicular helper (TFH) cells. In mouse models of hepatitis B virus (HBV) infection, TFH cells in the liver produce IL-21 in an HBV-dependent manner . Research demonstrates that IL-21 production is age-dependent, with adult mice showing higher HBV-dependent IL-21 production in the liver compared to young mice .
The IL-21 receptor (IL-21R) is expressed on multiple immune cell populations in mice, including T cells, B cells, and natural killer (NK) cells . The receptor is most closely related to the IL-2R β-chain and, like several other cytokine receptors, utilizes the common cytokine receptor γ-chain (γc) for signaling . IL-21R signaling involves the activation of Jak1 and Jak3 as well as Stat1, Stat3, and Stat5 transcription factors .
IL-21 has complex and context-dependent effects on B cell development and function:
It regulates IgG1 production and cooperates with IL-4 for the production of multiple antibody classes in vivo
IL-21 induces death of resting B cells but promotes differentiation of B cells into postswitch and plasma cells
This dual capacity explains how IL-21 can be proapoptotic for B cells in vitro yet critical for antigen-specific immunoglobulin production in vivo
IL-21 induces expression of both Blimp-1 and Bcl-6, key transcription factors that regulate B cell maturation and terminal differentiation
IL-21R−/− mice have markedly diminished IgG1 but greatly elevated IgE levels in response to antigen
Research using mouse models of HBV infection demonstrates significant age-dependent differences in IL-21 production and subsequent immune responses:
Adult mice show higher HBV-dependent IL-21 production in the liver compared to young mice
Young mice exhibit several IL-21-related immune deficits including:
These findings parallel human HBV infection patterns, where neonates and children usually develop chronic infection while adults typically clear the virus. The research suggests that decreased IL-21 production in younger subjects may hinder generation of crucial CD8+ T and B cell responses necessary for viral clearance .
IL-21 appears to play significant pathogenic roles in multiple autoimmune disease mouse models:
In the MRL-Fas(lpr) lupus-prone mouse model:
BXSB-Yaa mice, which develop a systemic lupus erythematosus-like disease, have greatly elevated IL-21 levels
From a clinical perspective, blocking IL-21 in SLE patients may represent a promising therapeutic approach based on mouse model findings
Different experimental approaches to disrupting IL-21 signaling can yield varying outcomes:
These differences highlight the complexity of IL-21 signaling and suggest possible compensatory mechanisms or differential effects on specific cell populations depending on whether the ligand or receptor is targeted.
The literature reveals apparently contradictory findings regarding IL-21's effects on γδT17 cells:
These seemingly contradictory findings may be reconciled by considering the tissue-specific distribution of γδT17 cell subsets:
Thus, IL-21 appears required for peripheral maintenance of Vγ4+ γδT17 cells but may have different effects on Vγ6+ γδT17 cells. Environmental factors and commensal bacteria may also influence these tissue-specific differences .
Several mouse models are available for investigating IL-21 biology:
Genetic models:
NSG mice (NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ) which lack T cells, B cells, NK cells and have deficient signaling for 6 cytokines including IL-21
Disease models:
Experimental models:
Researchers can manipulate IL-21 signaling through various approaches:
Genetic approaches:
Protein-based approaches:
Transfer approaches:
IL-21 appears to function at the interface between innate and adaptive immunity:
IL-21 limits NK cell responses while promoting antigen-specific T cell activation
IL-21 may serve as a mediator of the transition from innate to adaptive immunity
IL-21 contributes to effective anti-viral responses through:
When analyzing this role, researchers should:
Study both early (innate) and late (adaptive) timepoints in infection models
Examine IL-21's effects on both innate cells (NK, γδT) and adaptive cells (αβT, B cells)
Use both in vitro systems and in vivo models to capture the full spectrum of IL-21 functions
When investigating age-dependent effects of IL-21, researchers should consider:
Including multiple age groups in experimental design (young vs. adult mice)
Using adoptive transfer experiments between different age groups
Correlating findings in mouse models with human samples (as done in HBV studies comparing acute adult infection with chronic infection)
Examining age-specific differences in IL-21R expression and downstream signaling
Considering environmental factors that may change with age
Recent research has revealed that:
IL-21 signaling in γδT17 cells exacerbates experimental autoimmune encephalomyelitis (EAE)
IL-21 is required for the peripheral maintenance of Vγ4+ γδT17 cells but is dispensable for their thymic development
The role of IL-21 in EAE appears to be complex and may involve both direct effects on pathogenic cell populations and indirect effects on regulatory mechanisms
IL-21 functions within a complex network of cytokines:
IL-21 cooperates with IL-4 for the production of multiple antibody classes in vivo
IL-21R utilizes the common cytokine receptor γ-chain (γc) shared with IL-2, IL-4, IL-7, IL-9, and IL-15
NSG mice lack signaling for 6 cytokines including IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21
Understanding the hierarchical and synergistic relationships between these cytokines requires careful experimental design with appropriate controls
Several areas of IL-21 biology show apparently contradictory results that merit further study:
Effects on γδT17 cells: decreased in spleen/LNs but increased in lung/peritoneal cavity in some studies
B cell effects: pro-apoptotic for resting B cells but promotes differentiation in activated B cells
Tissue-specific effects: different outcomes in different anatomical locations
Age-dependent effects: different roles in young versus adult immune responses
These contradictions highlight the context-dependent nature of IL-21 function and suggest the need for more nuanced experimental approaches.
Researchers studying IL-21 should consider multiple detection methods:
Gene expression:
Protein detection:
Flow cytometry for intracellular IL-21 in specific cell populations
Immunohistochemistry for tissue localization
ELISA for secreted IL-21
Functional assays:
B cell differentiation and antibody production as readouts of IL-21 activity
T cell activation and proliferation assays
Reporter systems for IL-21 signaling
When designing IL-21 studies, researchers should include appropriate controls:
Genetic controls:
Wild-type littermates for IL-21−/− or IL-21R−/− mice
Isotype controls for blocking antibodies or fusion proteins
Mixed bone marrow chimeras to distinguish cell-intrinsic from cell-extrinsic effects
Disease model controls:
Non-autoimmune strains when studying autoimmune models
Uninfected controls when studying infection models
IL-21 is a four α-helix bundle cytokine closely related to IL-2, IL-7, and IL-15 . The functional receptor for IL-21 is composed of the IL-21 receptor and the common γ-chain, which is expressed on various hematopoietic cells including T, B, NK, and dendritic cells . This receptor composition allows IL-21 to exert pleiotropic effects on both cellular and humoral immune responses .
IL-21 plays a crucial role in the regulation of immune responses. It stimulates the proliferation of lymphocytes, enhances the cytotoxicity of CD8+ T cells and NK cells, and promotes the differentiation of B cells into plasma cells . Additionally, IL-21 is involved in the differentiation of naive CD4+ T cells towards T helper 17 (TH17) cells and follicular T helper (TFH) cells . These functions make IL-21 an important cytokine in both innate and adaptive immunity.
Recombinant mouse IL-21 is a protein optimized for use in cell culture, differentiation studies, and functional assays . It is typically produced in E. coli and purified to high standards, with purities greater than 95% and endotoxin levels below 0.1 ng/μg . The recombinant protein is used in various research applications, including: